Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.7951
-0.1195 (-13.07%)
At close: Nov 16, 2026, 4:00 PM EST
0.8400
+0.0449 (5.65%)
Pre-market: Nov 17, 2026, 8:35 AM EST

Lineage Cell Therapeutics Statistics

Total Valuation

LCTX has a market cap or net worth of $202.87 million. The enterprise value is $159.73 million.

Market Cap202.87M
Enterprise Value 159.73M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

LCTX has 255.15 million shares outstanding. The number of shares has increased by 10.54% in one year.

Current Share Class 255.15M
Shares Outstanding 255.15M
Shares Change (YoY) +10.54%
Shares Change (QoQ) -0.92%
Owned by Insiders (%) 4.82%
Owned by Institutions (%) 26.49%
Float 193.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 18.72
Forward PS 13.59
PB Ratio 3.00
P/TBV Ratio 8.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 91.12
EV / Sales 14.74
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.96, with a Debt / Equity ratio of 0.03.

Current Ratio 5.96
Quick Ratio 5.80
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 4.33% and return on invested capital (ROIC) is -178.36%.

Return on Equity (ROE) 4.33%
Return on Assets (ROA) -20.01%
Return on Invested Capital (ROIC) -178.36%
Return on Capital Employed (ROCE) -32.99%
Weighted Average Cost of Capital (WACC) 13.40%
Revenue Per Employee $140,727
Profits Per Employee $22,766
Employee Count77
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

Income Tax -4.80M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.71% in the last 52 weeks. The beta is 1.69, so LCTX's price volatility has been higher than the market average.

Beta (5Y) 1.69
52-Week Price Change -57.71%
50-Day Moving Average 0.99
200-Day Moving Average 1.29
Relative Strength Index (RSI) 33.69
Average Volume (20 Days) 1,935,427

Short Selling Information

The latest short interest is 24.35 million, so 9.54% of the outstanding shares have been sold short.

Short Interest 24.35M
Short Previous Month 29.09M
Short % of Shares Out 9.54%
Short % of Float 12.60%
Short Ratio (days to cover) 17.41

Income Statement

In the last 12 months, LCTX had revenue of $10.84 million and earned $1.75 million in profits.

Revenue10.84M
Gross Profit -10.30M
Operating Income -30.38M
Pretax Income -2.92M
Net Income 1.75M
EBITDA -29.62M
EBIT -30.38M
Earnings Per Share (EPS) -$0.09
Full Income Statement

Balance Sheet

The company has $45.18 million in cash and $2.03 million in debt, with a net cash position of $43.15 million or $0.17 per share.

Cash & Cash Equivalents 45.18M
Total Debt 2.03M
Net Cash 43.15M
Net Cash Per Share $0.17
Equity (Book Value) 65.94M
Book Value Per Share 0.27
Working Capital 39.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.82 million and capital expenditures -$636,000, giving a free cash flow of -$26.46 million.

Operating Cash Flow -25.82M
Capital Expenditures -636,000
Depreciation & Amortization 763,000
Net Borrowing -46,000
Free Cash Flow -26.46M
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross margin is -95.04%, with operating and profit margins of -280.34% and 16.18%.

Gross Margin -95.04%
Operating Margin -280.34%
Pretax Margin -26.94%
Profit Margin 16.18%
EBITDA Margin -273.30%
EBIT Margin -280.34%
FCF Margin n/a

Dividends & Yields

LCTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.54%
Shareholder Yield -10.54%
Earnings Yield -11.12%
FCF Yield -13.04%

Analyst Forecast

The average price target for LCTX is $5.50, which is 591.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.50
Price Target Difference 591.74%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 60.09%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.

Last Split Date Oct 31, 1997
Split Type Forward
Split Ratio 3:1

Scores

LCTX has an Altman Z-Score of -0.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.61
Piotroski F-Score 2